MannKind Corp. (MNKD)

[jimmac]

I think Edstrom was canned because he tripled
Afrezza product manufacturing last summer
without first seeing the increase in orders.

He saw the bigger batch reduces
cost but Al saw it as stupid waste.

Genzyne (Sanofi diabeties div.) like Edstrom
and he was initially hired to seal the deal.

He's 65 and just wants another year (see yesterdays 8k). Thats gives Al some cushion
finding a CEO that can take MNKD to the next growth level.

I'm expecting some news about new
board members coming on the team.


We're also still waiting to hear an update on the 4 other
products to use the Technosphere inhaler.
That has been in the background, but no PR's yet.
That's the secret other reason Sanofi likes MNKD.
The pain management inhaler would be the biggest news.

Sanofi has 34 meds and inhalers for some of them
would make things easier for alot of patients.
That inhaler is a niche product covered by over
30 patents controlled by MNKD.

Food for thought.


All just my opinion.